Pharmaceuticals and Healthcare Reports Raynauds Disease Market | Page 2

- The report reviews key players involved Raynauds Disease therapeutics and enlists all their major and minor
projects
- The report assesses Raynauds Disease therapeutics based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Raynauds Disease
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain
competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Raynauds Disease
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Raynauds Disease pipeline depth and focus of
Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most
attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove
them from pipeline
Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/raynauds-disease-pipelinereview-h2-2016/request-sample
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Raynauds Disease Overview 6
Therapeutics Development 7
Pipeline Products for Raynauds Disease - Overview 7
Raynauds Disease - Therapeutics under Development by Companies 8
Raynauds Disease - Pipeline Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
Raynauds Disease - Products under Development by Companies 12
Raynauds Disease - Companies Involved in Therapeutics Development 13
Allergan Plc 13
Apricus Biosciences, Inc. 14
Covis Pharmaceuticals, Inc. 15
Human Stem Cells Institute 16
Raynauds Disease - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
acetylcysteine - Drug Profile 26